Therefore, we specifically analysed IL-1β, IL-6, IL-8, IL-10, TNF-α and MCP-1 as these pro-inflammatory mediators constitute a significant source of morbidity after endovascular AAA repair in most studies [12]–[14], [16], [25], [26]. The gene discussed is CCL2; the disease is triple-A syndrome.